1-216190379-AAAAGAAAGAAAG-AAAAGAAAG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000307340.8(USH2A):c.4252-16_4252-13del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00702 in 1,597,562 control chromosomes in the GnomAD database, including 524 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 282 hom., cov: 31)
Exomes 𝑓: 0.0042 ( 242 hom. )
Consequence
USH2A
ENST00000307340.8 splice_polypyrimidine_tract, intron
ENST00000307340.8 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.46
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-216190379-AAAAG-A is Benign according to our data. Variant chr1-216190379-AAAAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 178671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216190379-AAAAG-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.4252-16_4252-13del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000307340.8 | NP_996816.3 | |||
USH2A | NM_007123.6 | c.4252-16_4252-13del | splice_polypyrimidine_tract_variant, intron_variant | NP_009054.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.4252-16_4252-13del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_206933.4 | ENSP00000305941 | P1 | |||
USH2A | ENST00000366942.3 | c.4252-16_4252-13del | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000355909 | |||||
USH2A | ENST00000674083.1 | c.4252-16_4252-13del | splice_polypyrimidine_tract_variant, intron_variant | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.0337 AC: 5103AN: 151604Hom.: 277 Cov.: 31
GnomAD3 genomes
AF:
AC:
5103
AN:
151604
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00955 AC: 2339AN: 244842Hom.: 115 AF XY: 0.00742 AC XY: 983AN XY: 132502
GnomAD3 exomes
AF:
AC:
2339
AN:
244842
Hom.:
AF XY:
AC XY:
983
AN XY:
132502
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00421 AC: 6090AN: 1445842Hom.: 242 AF XY: 0.00379 AC XY: 2728AN XY: 719300
GnomAD4 exome
AF:
AC:
6090
AN:
1445842
Hom.:
AF XY:
AC XY:
2728
AN XY:
719300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0338 AC: 5130AN: 151720Hom.: 282 Cov.: 31 AF XY: 0.0323 AC XY: 2395AN XY: 74142
GnomAD4 genome
AF:
AC:
5130
AN:
151720
Hom.:
Cov.:
31
AF XY:
AC XY:
2395
AN XY:
74142
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 17, 2015 | 4252-16_4252-13delCTTT in Intron 19 of USH2A: This variant is not expected to h ave clinical significance because it does not alter the splice consensus sequenc e and it has been identified in 10.9% (466/4264) African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 01, 2018 | - - |
Retinitis Pigmentosa, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Retinitis pigmentosa-deafness syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Usher syndrome type 2A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at